AMGN logo

AMGNAMGEN Inc.

$327.61
$9.19
(2.73%)
Today
Updated: 01:11 PM EDT
EarningsAug 4
Mkt Cap$181.77B
Vol759,897.00
News
all
press releases
Here's Why Amgen (AMGN) is a Strong Momentum Stock
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Zacks
News Placeholder
More News
News Placeholder
AMGEN TO PRESENT AT JEFFERIES GLOBAL HEALTHCARE CONFERENCE
AMGEN TO PRESENT AT JEFFERIES GLOBAL HEALTHCARE CONFERENCE AMGEN TO PRESENT AT JEFFERIES GLOBAL HEALTHCARE CONFERENCE PR Newswire THOUSAND OAKS, Calif., May 29, 2026 THOUSAND OAKS, Calif., May 29, 2026 /PRNewswire/ --Amgen (NASDAQ:AMGN) will present at Jefferies Global Healthcare Conference at9:55...
PR Newswire
News Placeholder
J&J Stock Gains Nearly 12% Year to Date: Buy, Sell or Hold Now?
JNJ is up nearly 12% YTD as strong oncology drug growth, MedTech demand and pipeline advances help offset Stelara patent-loss pressure.
Zacks
News Placeholder
Eli Lilly Stock Hits Record Highs, Becomes First Pharmaceutical Firm Worth $1 Trillion
Eli Lilly (LLY) stock has surged to new record highs of over $1,000 a share, cementing its position as one of the market's most dominant growth stories and the first pharmaceutical firm worth $1 trillion.
Zacks
News Placeholder
Novo Nordisk vs. Amgen: Which Pharma Stock Is the Better Buy?
NVO and AMGN square off as GLP-1 leadership, pipeline depth and diversification shape a compelling healthcare stock comparison.
Zacks
News Placeholder
Ember LifeSciences announces new strategic investments boosting Series A to $27M
Ember LifeSciences announces new strategic investments boosting Series A to $27M Ember LifeSciences announces new strategic investments boosting Series A to $27M PR Newswire LOS ANGELES, May 27, 2026 LOS ANGELES, May 27, 2026 /PRNewswire/ -- EmberLifeSciences, Inc., ("Ember") a leading provider of...
PR Newswire
News Placeholder
The Zacks Analyst Blog Highlights RTX, Wells Fargo, Amgen, Daily Journal and Tandy Leather
RTX, Wells Fargo and Amgen headline Zacks research as aerospace demand, banking shifts and drug launches drive outlooks.
Zacks
News Placeholder
Top Stock Reports for RTX, Wells Fargo & Amgen
RTX builds a $271B backlog on defense demand and recovering air travel, but tariffs and supply-chain issues cloud growth.
Zacks
News Placeholder
AMGN Stock Down 13% in 3 Months: Buy the Dip or Book Profits?
Amgen faces LOE headwinds and pricing pressure, yet key growth drugs and biosimilars continue gaining traction.
Zacks
News Placeholder
Amgen Inc. (AMGN) is Attracting Investor Attention: Here is What You Should Know
Amgen (AMGN) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Zacks
<
1
2
...
>